Top Markets
#1 Status Status +24.09%
#2 Ontology Gas Ontology Gas +22.68%
#3 EXOD EXOD +22.08%
#4 ETHGas ETHGas +17.93%
#5 The Black Bull The Black Bull +15.99%
#6 Fake World Assets Fake World Assets +11.81%
#7 aelf aelf +10.18%
#8 Derive Derive +8.58%
#9 Gas Gas +8.36%
#10 Tornado Cash Tornado Cash +7.15%
Coin of the day
Status Status
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Clasificación en acciones #25506
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Precio por acción
$1.34
Última sincronización: 2024-02-14
Capitalización bursátil
$48.96M
Cambio (1 día)
-12.94%
Cambio (1 año)
0.00%
País
SE
Comercio Promore Pharma AB (publ) (PROMO)

Categoría

Healthcare
Historial del precio de la acción de Promore Pharma AB (publ) (PROMO)
Precio más alto de cierre: $2.11 el 2024-02-01

Precio más bajo de cierre: $179.71 el 2017-07-01
Historial del precio de la acción de Promore Pharma AB (publ) desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 54.03%
2023 -86.45%
2022 -51.13%
2021 -52.08%
2020 -18.70%
2019 -67.83%
2018 -5.69%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.84 -18.14%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US